Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma

Biomark Med. 2017 Feb;11(2):141-149. doi: 10.2217/bmm-2016-0283. Epub 2016 Dec 8.

Abstract

Aim: IL-27 has potent antitumor effects. We aimed to examine the contribution of single nucleotide polymorphisms in IL-27 to the risk of papillary thyroid carcinoma (PTC).

Materials & methods: IL-27 rs153109 and rs17855750 were analyzed in 496 PTC patients and 629 controls, using a polymerase chain reaction-restriction fragment length polymorphism method.

Results: The rs153109 AG and AG/GG genotypes were significantly associated with increased risks for PTC. Significantly increased PTC risk was also associated with rs17855750 GT and GT/GG genotypes. Combined genotypes of rs153109 AG/GG and rs17855750 GT/GG increased the risk of PTC (p < 0.05).

Conclusion: These findings showed that IL-27 rs153109 and rs17855750 might be related to the tumorigenesis of PTC.

Keywords: IL-27; papillary thyroid carcinoma; risk; rs153109; rs17855750; single nucleotide polymorphism.

MeSH terms

  • Adult
  • Alleles
  • Carcinoma, Papillary / diagnosis
  • Carcinoma, Papillary / genetics*
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Interleukin-27 / genetics*
  • Male
  • Middle Aged
  • Odds Ratio
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms / diagnosis
  • Thyroid Neoplasms / genetics*

Substances

  • Interleukin-27